Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T19:24:29.806Z Has data issue: false hasContentIssue false
  • English
  • Français

Why Science Cannot Tame Politics: The New EU Comitology Rules and the Centralised Authorisation Procedure of GMOs

Published online by Cambridge University Press:  20 January 2017

Christoph Klika ,
Jinhee Kim  and
Esther Versluis
Christoph Klika
Affiliation:
Department of Political Science, Maastricht University
Jinhee Kim
Affiliation:
Department of Political Science, Maastricht University
Esther Versluis
Affiliation:
European Regulatory Governance at the Department of Political Science, Maastricht University
Get access Rights & Permissions [Opens in a new window]

Abstract

The centralised authorisation of GMOs in the European Union (EU) has received considerable academic attention in recent years, partly due to the fact thatMember States have not been able to agree on authorisation decisions in the comitology committee. As a consequence, these authorisations are given by the European Commission. These decisions are invariably in favour of authorisation despite the fact that Member States had been divided on this issue. Apart from the on-going discussions on a possible reform of the GMO authorisation (allowing for national restrictions or prohibitions), the new comitology rules brought about by the Lisbon Treaty are of equal importance as they might affect the authorisation of GMOs. In this article we discuss some of the changes to comitology and present empirical material on the first authorisation decisions after the entering into force of the new comitology rules. By drawing on delegation theory we will argue that, for the time being, the level of politicisation ofGMOauthorisation is unlikely to change.

Type
Articles
Information
European Journal of Risk Regulation , Volume 4 , Issue 3 , September 2013 , pp. 327 - 334
Copyright
Copyright © Cambridge University Press 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 van Asselt, Marjolein B. A. and Vos, Ellen, “Wrestling with uncertain risks: EU regulation of GMOs and the uncertainty paradox”, 11(1-2) Journal of Risk Research (2008), pp. 281–300 CrossRefGoogle Scholar.

2 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed, OJ L 268/1.

3 The referral of a decision to the Council is an extremely rare case, and the vast majority of these cases stem from GMO authorisations in the SCFCAH; see e.g. Report from the Commission on the working of the committees during 2010, COM(2011) 879 final from 12.12.2011.

4 Such a ban is based on Art. 23 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberative release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC, OJ L 106/1.

5 Thomas Christiansen and Josine Polak, “Comitology between Political Decision-Making and Technocratic Governance: Regulating GMOs in the European Union,” EIPASCOPE, (2009).

6 See Poli, Sara, “The Commission's New Approach to the Cultivation of Genetically Modified Organisms”, 1(4) European Journal of Risk Regulation (2010), pp. 339–344 CrossRefGoogle Scholar.

7 Art. 290 and 291 TFEU.

8 Weimer, Maria, “What Price Flexibility? – The Recent Commission Proposal to Allow for National “Opt-Outs” on GMO Cultivation under the Deliberate Release Directive and the Comitology Reform Post-Lisbon”, 1(4) European Journal of Risk Regulation (2010), pp. 345–352 CrossRefGoogle Scholar.

9 Paskalev, Vesco, “Can Science Tame Politics: The Collapse of the New GMO Regime in the EU”, 3(2) European Journal of Risk Regulation (2012), pp. 190–201 CrossRefGoogle Scholar.

10 Tallberg, Jonas, “Delegation to Supranational Institutions: Why, How, and with What Consequences?”,25(1)West European Politics (2002), pp. 23–46 CrossRefGoogle Scholar.

11 See Majone, Giandomenico, “Two Logics of Delegation. Agency and Fiduciary Relations in EU Governance”, 2(1) European Union Politics (2001), pp. 103–122 CrossRefGoogle Scholar.

12 See McCubbins, Mathew D., Noll, Roger G. and Weingast, Barry R., “Administrative Procedures as Instruments of Political Control”, 3(2) Journal of Law, Economics and Organization (1987), pp. 243–277 Google Scholar; Moe, Terry, “The positive theory of public bureaucracy”, in Mueller, Dennis C. (ed.) Perspectives on public choice. A handbook (Cambridge: Cambridge University Press, 1997)Google Scholar.

13 Case 9/56, Meroni & Co., Industrie Metallurgische S.p.A. v. High Authority, (1958) ECR-133.

14 Christensen, Jørgen Grønnegaard and Nielsen, Vibeke Lehmann, “Administrative capacity, structural choice and the creation of EU agencies”, 17(2) Journal of European Public Policy (2010), pp. 176–204 CrossRefGoogle Scholar; Peers, Steve and Costa, Marios, “Accountability for Delegated and Implementing Acts after the Treaty of Lisbon”, 18(3) European Law Journal (2012), pp. 427–460 CrossRefGoogle Scholar.

15 Stefan Griller and Andreas Orator,04/D40 “Meroni Revisited – Empowering European Agencies between Efficiency and Legitimacy”, NEWGOV New Modes of Governance Project (2007); Chamon, Merijn, “EU agencies between Meroni and Romano or the devil and the deep blue sea”, 48 Common Market Law Review (2011), 1055–1075 Google Scholar.

16 In most agencies the steering board (often called Management Board) is composed of by Member States’ representatives, the Commission and increasingly the European Parliament (EP).

17 The very existence of comitology is in fact an expression of Member States’ concern to retain control in risk regulation. See Previdi, Ernesto, “The Organisationof Public and Private responsibilities in European Risk Regulation”, in Joerges, Christian, Ladeur, Karl-Heinz and Vos, Ellen (eds) Integrating Scientific Expertise into Regulatory Decision Making (Baden-Baden: Nomos Verlagsgesellschaft, 1997)Google Scholar.

18 See Gardner, John S., “The European Agency for the Evaluation of Medicines and European Regulation of Pharmaceuticals”, 2(1) European Law Journal (1996), pp. 48–82 CrossRefGoogle Scholar. Krapohl, Sebastian, “Credible Commitment in Non-Independent Regulatory Agencies: A Comparative Analysis of the European Agencies for Pharmaceuticals and Foodstuffs”, 10(5) European Law Journal (2010), pp. 518–538 CrossRefGoogle Scholar.

19 For instance, the European Maritime Safety Agency (EMSA) was established in the aftermath of the Erika (1999) and Prestige (2002) oil tanker accidents, and the European Centre for Disease Prevention and Control (ECDC), was created in order to respond faster to health threats such as SARS. In June 2012 Council, EP and Commission agreed on a common approach towards a more streamlined governance arrangement of EU agencies. To what extent these arrangements affect the functioning of EU agencies remains to be seen in the future.

20 See Majone, Giandomenico, “The regulatory state and its legitimacy problems”, 22(1) West European Politics (1999), pp. 1–24 CrossRefGoogle Scholar.

21 See Skogstad, Grace, “Legitimacy and/or policy effectiveness?: network governance and GMO regulation in the European Union”, 10(3) Journal of European Public Policy (2003), pp. 329 et sqq CrossRefGoogle Scholar.

22 Majone, Giandomenico, “Foundations of Risk Regulation: Science, Decision-Making, Policy Learning and Institutional Reform”, 1(1) European Journal of Risk Regulation (2010), pp. 5–19 CrossRefGoogle Scholar.

23 See Giandomenico Majone, “Two Logics of Delegation”, supra note 11.

24 Marjolein B. A. van Asselt and Ellen Vos, “Wrestling with uncertain risks”, supra note 1.

25 This number is derived from EFSA's Register of Questions (see http://registerofquestions.efsa.europa.eu/roqFrontend/questionsListLoader?panel=NDA&foodsectorarea=26) by searching for ‘Output’. The search was restricted to opinions by a scientific panel, using ‘1829/2003’ in the title to single out those opinions which are related to respective applications, renewal of applications and requests to evaluate national safeguard measures.

26 Chalmers, Damian, “‘Food for Thought’: Reconciling European Risks and Traditional Ways of Life”, 66(4) The Modern Law Review (2003), pp. 532–562 CrossRefGoogle Scholar.

27 Kritikos, Mihail, “Traditional risk analysis and releases of GMOs into the European Union: space for non-scientific factors?”, 34(3)European Law Review (2009), pp. 405–432 Google Scholar.

28 Tiberghien, Yves, “Competitive Governance and the Quest for Legitimacy in the EU: the Battle over the Regulation of GMOs since the mid-1990s”, 31(3) Journal of European Integration (2009), pp. 389–407 CrossRefGoogle Scholar.

29 Pollack, Mark A. and Shaffer, Gregory C., When cooperation fails: The International Law and Politics of Genetically Modified Foods (Oxford: Oxford University Press, 2009)CrossRefGoogle Scholar. Everson, Michelle and Vos, Ellen, “The scientification of politics and the politicisation of science”, in Everson, Michelle and Vos, Ellen (eds), Uncertain Risks Regulated (Abingdon et al.: Routledge, 2009)Google Scholar.

30 Thomas Christiansen and Josine Polak, “Comitology between Political Decision-Making and Technocratic Governance”, supra note 5.

31 Vos, Ellen and Wendler, Frank, “Food Safety Regulation at the EU level”, in Vos, Ellen and Wendler, Frank (eds) Food Safety Regulation in Europe: A comparative institutional analysis”, (Antwerpen: Intersentia, 2006)Google Scholar.

32 Blom-Hansen, Jens and Brandsma, GijsJan, “The EU Comitology System: Intergovernmental Bargaining and Deliberative Supranationalism?”, 47(4) Journal of Common Market Studies (2009), pp. 719–740 CrossRefGoogle Scholar.

33 Lee, Maria, EU Regulation of GMOs: Law and Decision Making for a New Technology (Cheltenham and Northampton: Edward Elgar, 2008), at p. 102 CrossRefGoogle Scholar.

34 See Case T-13/99 Pfizer Animal Health SA v Council of the European Union (2002) ECR II-03305

35 Vesco Paskalev, “Can Science Tame Politics”, supra note 9.

36 Maria Lee, EU Regulation of GMOs: Law and Decision Making for a New Technology, supra note 33; Maria Weimer, “Legitimacy through Precaution in European Regulation of GMOs? From the Standpoint of Governance as Analytical Perspective”, in Christian Joerges and Poul F. Kjaer (eds), Transnational Standards of Social Protection Contrasting European and International Governance, vol 5 (ARENA Report No 5/08, RECON Report No 4 2008), p. 195.

37 See 87/373/EEC: Council Decision of 13 July 1987 laying down the procedures for the exercise of implementing powers conferred on the Commission. OJ L 197/33; Council Decision 1999/468/EC of 28 June 1999 laying down the procedures for the exercise of implementing powers conferred on the Commission. OJ 1999, L 184/23; Council Decision 2006/512/EC of 17 July 2006amending Decision 1999/468/EC laying down the procedures for the exercise of implementing powers conferred on the Commission, OJ 2006, L 200/11.

38 See Proposal for a Regulation of the European Parliament and of the Council laying down the rules and general principles concerning mechanisms for control by Member States of the Commission's exercise of implementing powers, COM (2010) 83 final from 9.3.2010.

39 See Art. 290 and 291 TFEU.

40 Brandsma, Gijs Jan and Blom-Hansen, Jens, “Negotiating the Post- Lisbon Comitology System: Institutional Battles over Delegated Decision-Making”, 50(6) Journal of Common Market Studies (2012), pp. 939–957 CrossRefGoogle Scholar.

41 Regulation (EU) 182/2011 of the European Parliament and of the Council laying down the rules and general principles concerning mechanisms for control by Member States of the Commission’s exercise of implementing powers, OJ 2011, L 55/13.

42 Rules of procedure for the appeal committee (Regulation (EU) No 182/2011). Adopted by the appeal committee on 29 March 2011, OJ 2011, C 183/13.

43 Craig, Paul, “Delegated acts, implementing acts and the new Comitology Regulation”, 36(5) European Law Review (2011), pp. 671 et sqq Google Scholar.

44 Gijs Jan Brandsma and Jens Blom-Hansen, “Negotiating the Post-Lisbon Comitology System”, supra note 40.

45 See Regulation (EU) 182/2011, supra note 41, Art. 5.

46 Rules of procedure for the appeal committee, supra note 42, Art. 5.

47 See Summary Record, Plenary Meeting of the Advisory Group on the Food Chain and Animal and Plant Health, SANCO.03/VK D(2011), 14 March 2011.

48 See Commission website Comitology Register; <http://ec.europa.eu/transparency/regcomitology/index.cfm?do=FAQ.FAQ> (last accessed on 5 August 2013).

49 See Council Decision 1999/468/EC, supra note 37.

50 See Regulation (EU) 182/2011 supra note 41, Art. 6(3).

51 Paul Craig, “Delegated acts”, supra note 43.

52 Ibid.

53 Mihail Kritikos, “Traditional risk analysis and releases of GMOs”, supra note 27.

54 The respective Commission decisions can be found in the Eur-lex database. A search has been conducted restricting results to decisions under the 1829/2003 Regulation with a time span between February 2012 and November 2012 yielding the six GMO authorisations under consideration here. (The last previous Commission decisions from December 2011 are based on comitology no-votes from February 2011, thus before the new comitology regime entered into force in March the same year.)

55 Declarations on Council Decision 1999/468/EC of 28 June 1999 laying down the procedures for the exercise of implementing powers conferred on the Commission, OJ 1999, C 203/1.

56 Ibid.

57 Damian Chalmers, “Food for Thought”, supra note 26.

58 Giandomenico Majone, “Foundations of Risk Regulation”, supra note 22.

59 Maria Weimer, “Legitimacy through Precaution in European Regulation of GMOs?”, supra note 36.

60 Jürgen Neyer, 13(5) “The deliberative turn in integration theory,” Journal of European Public Policy (2006).

61 Loren A. King, 16(1) “Deliberation, Legitimacy, and Multilateral Democracy,” Governance: An International Journal of Policy, Administration, and Institutions (2003).

62 Damian Chalmers, “Food for Thought”, supra note 26.

63 Council conclusions, Genetically Modified Organisms (GMOs) (16882/08), Brussels, 5 December 2008.

64 Proposal for a Regulation of the European Parliament and of the Council amending Directive 2001/18/EC as regards the possibility for the Member States to restrict or prohibit the cultivation of GMOs in their territory, COM(2010) 375 final from 13.7.2010.

65 See Sara Poli, “The Commission's New Approach”, supra note 6.

66 See Euractiv, “First ‘Citizens’ Initiative to call for GM crop freeze”, 6 October 2010, available on the internet at http://www.euractiv.com/cap/citizens-initiative-call-gm-crop-news-498524 (last accessed (3 September 2012).

67 Michael Dougan, 48 “What are we to make of the Citizens’ Initiative?,” Common Market Law Review (2011).

68 See Press release 3152nd Council meeting Environment (7478/12), Brussels, 9 March 2012.